JANUS G3 液体处理工作站，具有多项独特的系统具有良好的开放性、灵活性和扩展性。可整合各种不同的功能模块，自动化完成基因、蛋白研究、药物筛选和分析科学等实验过程。实验结果可靠，重复性好，有效增加通量，提升工作效率，是实验室自动化设备的理想之选。从台式特定应用工作站到复杂的定制整合型解决方案，新一代JANUS G3 产品线充分满足现代药物研发和诊断研究的工作流程要求，包括生物治疗药物、细胞筛选和细胞影像应用、基因组学和基于DNA/RNA的应用、药物滥用检测等。

JANUS G3自动化应用范围：常规液体处理、自动化核酸提取和纯化、PCR反应体系的建立、核酸浓度归一化处理、蛋白酶解、点靶、蛋白纯化、结晶学筛选、ELISA、先导化合物合成高通量筛选，药物吸收、分布、代谢等毒理特异性实验、分析实验中质谱样品准备、细胞培养、细胞组学以及血样汇集处理等实验。

At Revvity, we regard "impossibility" as inspiration and "inability" as the driving force. Revvity offers health science solutions, cutting - edge technologies and professional services, with its business covering the entire end - to - end process of scientific research exploration, development, diagnosis, and treatment. Relying on years of in - depth cultivation in fields such as translational multi - omics technology, biomarker identification, imaging, disease prediction, screening, detection and diagnosis, and informatics, Revvity is using the power of technology to break through the boundaries of human potential.

In 2023, Revvity's turnover exceeded $2.7 billion. It has more than 11,000 employees worldwide and provides diverse services for customers such as pharmaceutical and biotechnology enterprises, diagnostic laboratories, scientific research institutions and government agencies. The company is a member of the S&P 500 Index, and its customers are spread across more than 190 countries and regions around the world.